University of Connecticut

Events Calendar

UConn Dermatology Grand Rounds

Wednesday, November 6, 2019
8:00am – 12:00pm

UConn Health
21 South Road, 2nd Floor


“JAK inhibitors in Dermatology”

Provided by University of Connecticut School of Medicine Office of Community and Continuing Medical Education and the Department of Dermatology

Speaker: Gillian Weston, MD – Chief Resident, Department of Dermatology, UConn School of Medicine Date: Wednesday, November 6, 2019 Time: Lecture: 8am – 9:30am, Patient viewing: 9:30am - 12pm Location: University of Connecticut Health Center, Dermatology Department, 21 South Road, 2nd Floor, Conference Room

Target Audience: UCHC dermatologists and dermatology residents. All other podiatrists, nurses, nurse practitioners, residents, students, and greater Hartford dermatologists are encouraged to attend.

Objectives: Participants will (be able to):

a. Recite the evidence or expert opinion associated with using JAK inhibitors in management of dermatologic conditions. b. Identify one or more barriers to implementing use of JAK inhibitors in treating dermatologic conditions. c. Describe one or more strategies necessary either to begin using JAK inhibitors in treatment of dermatologic conditions or overcome obstacles to prescribing JAK inhibitors for treatment of dermatologic conditions.

Accreditation: The University of Connecticut School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Connecticut School of Medicine designates this live educational activity for a maximum of 4 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Conflict of Interest Policy: All faculty members participating in CME activities provided by the University of Connecticut School of Medicine are required to disclose to the program audience any actual or apparent conflict of interest related to the content of their presentations. Program planners have an obligation to resolve any actual conflicts of interest and share with the audience any safeguards put in place to prevent commercial bias from influencing the content.

Neither the activity director, planning committee members, nor the speaker, Dr. Weston, have a financial interest/arrangement or affiliation with any organizations that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation.

Dr. Weston will be discussing the use of/and devices: Tofacitinib- psoriasis, alopecia areata, vitiligo, atopic dermatitis, Ruxolitinib- alopecia areata, vitiligo, & Baricitinib- atopic dermatitis, psoriasis, alopecia areata.

This CME activity has no commercial support associated with it.

Evaluations: Participants are required to complete an electronic evaluation in order to obtain CME Credits. An email from with instructions will be sent to participants. Please complete the evaluation within one week of receiving t


Diane Whitaker-Worth, MD -

Continuing Medical Education (primary), UConn Master Calendar

Control Panel